T1a triple negative breast cancer has the worst prognosis among all the small tumor (<1 cm) of TNBC and HER2-rich subtypes
Author:
Publisher
AME Publishing Company
Subject
Surgery
Link
https://gs.amegroups.com/article/download/63141/pdf
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Crocin inhibit the metastasis of MDA-MB-231 cell line by suppressing epithelial to mesenchymal transition through WNT/β-catenin signalling pathway;Annals of Medicine & Surgery;2024-01-08
2. Tumor characteristics and survival rate of HER2-low breast cancer patients: a retrospective cohort study;Scientific Reports;2023-10-04
3. Impact of Adjuvant Chemotherapy on Survival Benefit in T1N0 Triple Negative Breast Cancer Based on SEER Database by Age Group;2023-06-07
4. Comparative analysis of the effectiveness of neoadjuvant systemic therapy and primary surgical treatment of patients with <i>BRCA<i/>-associated triple-negative T1 breast cancer;HERALD of North-Western State Medical University named after I.I. Mechnikov;2023-01-20
5. Retrospective Study of Treatment Patterns and Natural History of Patients with T1a/b N0 Triple-Negative Breast Cancers: A Single-Institution Experience;Oncology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3